US SB648 | 2015-2016 | 114th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on March 4 2015 - 25% progression, died in committee
Action: 2015-03-04 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Medicare Formulary Improvement Act of 2015 This bill amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require a sponsor offering a prescription drug plan (PDP) to include all covered part D drugs in the following categories and classes of drugs in the formulary: (1) anticonvulsants, (2) antidepressants, (3) antineoplastics, (4) antipsychotics, (5) antiretrovirals, and (6) immunosuppressants for the treatment of transplant rejection. Currently the Secretary of Health and Human Services is required to identify categories and classes of drugs of clinical concern. The Secretary is required, however, to establish any exceptions that permit a PDP sponsor to exclude from its formulary a particular covered part D drug only through promulgation of a regulation, including a public notice and comment period.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Medicare Formulary Improvement Act of 2015

Sponsors


History

DateChamberAction
2015-03-04SenateRead twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback